Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Yowza123

IVITF

Invictus' rates well in Alan Brochstein's Newsletter

Invictus given a very low price-to-tangible book value in Alan Brochstein'...

August 11, 2019

LEXX

Lexaria/ Canada National Research Council results

No chemical modification or degradation of Active Pharmaceutical Ingredients...

August 10, 2019

IVITF

Acreage Pharms Oil Sales License

Health Canada site shows AP now has its Oil Sales License.  https://www...

August 10, 2019

IVITF

RE:RE:RE:RE:RE:RE:RE:Only 7.500 per year??

When product starts shipping to Germany under the 2,000 Kg/yr for 5 yrs deal,...

August 7, 2019

IVITF

RE:RE:RE:RE:RE:RE:RE:GENE is making sales.

How can you say twice that the company is not selling and then say that you...

July 31, 2019

IVITF

RE:RE:RE:RE:RE:RE:GENE is making sales.

This is where they mention the scrapping:https://www.barrons.com/press...

July 31, 2019

IVITF

RE:RE:RE:GENE is making sales.

It could be done subtely. It does't have to tarnish his reputation. The...

July 31, 2019

IVITF

RE:RE:RE:GENE is making sales.

It could be done subtely. It doesn't have to tarnish his reputation. The...

July 31, 2019

IVITF

RE:GENE is making sales.

The latest PR from the General Meeting shows that GS is no longer on the BOD....

July 31, 2019

LEXX

RE:RE:ALmost back to 69 gawking cents

I'm not selling you my shares. 

July 29, 2019

LEXX

RE:ALmost back to 69 gawking cents

Buy on the dips

July 28, 2019

V.HILL

RE:Hill Street/ Lexaria deal video

Here's the expanded deal with Lexaria: https://www.newswire.ca/news...

July 27, 2019

V.HILL

Hill Street/ Lexaria deal video

https://youtu.be/4wdf_1VeqvE

July 27, 2019

IVITF

RE:RE:RE:RE:RE:GM Results

The team page on their website says so. https://www.invictus-md.com/team

July 25, 2019

IVITF

GM Results

https://www.globenewswire.com/news-release/2019/07/25/1888297/0/en/Invictus...

July 25, 2019

IVITF

RE:RE:RE:losing

Sounds good. I'll put him in with the other couple of hundred !

July 23, 2019

IVITF

RE:losing

IMO it's better to wish people good luck making money. Didn't you...

July 23, 2019

IVITF

RE:on Jun 12, 2019

And when Phase 3 starts up we'll be looking at another 8,000 to 10,000 Kg...

July 18, 2019

IVITF

RE:RE:RE:RE:RE:Bottom

I wasn't inferring you were putting the company down. My point was: when...

July 17, 2019

IVITF

RE:RE:RE:Bottom

Hey fmab, I totally hear you. I agree with everything you posted. You're...

July 17, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Theralase Technologies Inc.

Theralase Technologies Inc. V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ... view more »